What is Nektar Therapeutics's change in other assets?

Nektar Therapeutics (NKTR) reported change in other assets of -$949K in Q1 2026.

How has Nektar Therapeutics's change in other assets changed year-over-year?

Nektar Therapeutics's change in other assets decreased by 115.9% year-over-year, from $5.96M to -$949K.

What is the long-term trend for Nektar Therapeutics's change in other assets?

Over 2 years (2021 to 2025), Nektar Therapeutics's change in other assets has grown at a 152.1% compound annual growth rate (CAGR), from $2.59M to $16.43M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Nektar Therapeutics NKTR Change in Other Assets

Change in Other Assets at other companies

AmgenAMGN

-$8M-104%

ImmunityBio, Inc.IBRX

$1.05M+1,152%

Apogee Therapeutics, Inc.APGE

-$155K-102%

ImmunomeIMNM

$5.1M+199%

Iovance Biotherapeutics, Inc.IOVA

$1.47M-54.9%

Kymera TherapeuticsKYMR

$3.57M+228%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's change in other assets?: Nektar Therapeutics (NKTR) reported change in other assets of -$949K in Q1 2026.
How has Nektar Therapeutics's change in other assets changed year-over-year?: Nektar Therapeutics's change in other assets decreased by 115.9% year-over-year, from $5.96M to -$949K.
What is the long-term trend for Nektar Therapeutics's change in other assets?: Over 2 years (2021 to 2025), Nektar Therapeutics's change in other assets has grown at a 152.1% compound annual growth rate (CAGR), from $2.59M to $16.43M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.